Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biomed Research International|April 16, 2013
Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomasNicolas Boisgerault, Jean-Baptiste Guillerme, Daniel Pouliquen, et al.
Frontiers in Immunology|August 15, 2022
The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression ProfilesPierre Autin, Sophie Deshayes, Juliette Lea, et al.
Current Gene Therapy|January 3, 2017
Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles VirusFerdaous Allagui, Carole Achard, Clarisse Panterne, et al.
Molecular Therapy Oncolytics|September 30, 2020
High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural MesotheliomaTiphaine Delaunay, Joelle Nader, Marion Grard, et al.
Journal of Extracellular Biology|June 28, 2024
<i>TP53</i> mutations correlate with the non-coding RNA content of small extracellular vesicles in melanomaMaureen Labbé, Estelle Menoret, Franck Letourneur, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapseNicolas Boisgerault, Timothy Kottke, Jose Pulido, et al.
Respiratory Research|April 5, 2024
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapyPauline Hulo, Sophie Deshayes, Judith Fresquet, et al.
Oncotarget|November 6, 2015
Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon responseCarole Achard, Nicolas Boisgerault, Tiphaine Delaunay, et al.
Pageof 4